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The envelope protein of Moloney murine leukemia virus mediates entry into mCAT-expressing cells. Attempts to change its receptor usage
through the insertion of ligands at various sites have been met with varying success. We have tested several sites in Env for insertion of apelin, a
small peptide ligand of the G-protein-coupled receptor APJ. Although most of the chimeric envelopes had retained their ability to infect mouse
cells none showed APJ-dependent entry. Insertion of a peptide linker Ser-Gly-Gly-Ser-Gly at either side of the apelin motif in one of the chimeric
envelopes resulted in an ability of the chimeric envelope to bind to and infect cells through APJ although with low efficiency. Several linker
sequences isolated by library selection for APJ-dependent infection were found to support entry, however none more efficiently than the original
SGGSG-linker. Hence, the immediate context of ligand presentation is critical for infectivity via a heterologous receptor.
© 2007 Elsevier Inc. All rights reserved.Keywords: Viral targeting; Envelope; Moloney murine leukemia virus; APJ; Apelin; LibraryIntroduction
Retroviruses are enveloped viral particles that enter their
target cells through fusion of the viral envelope with the cellular
membrane. This is achieved through the interaction of the viral
envelope glycoprotein with cellular receptors, followed by
conformational changes in the envelope protein which results in
penetration of the cellular membrane by a fusion peptide and
subsequent lipid-mixing (reviewed in Dutch et al., 2000).
Viral receptors are membrane-integral proteins in the plasma
membrane, encoded by the host cells, and as such fulfil
important cellular functions. The primary structures of viral
receptors bear no resemblance to one another. On the other
hand, the secondary structures contain, in most cases, many
transmembrane helices. This is indeed the case with gamma-
retroviral receptors and lentiviral co-receptors (Overbaugh
et al., 2001).
Even closely related viruses may use different receptors. For
example, the MLV group of gammaretroviruses has been⁎ Corresponding author. Fax: +45 86196500.
E-mail address: fsp@mb.au.dk (F.S. Pedersen).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.01.021divided into ecotropic (uses mCAT1), amphotropic (uses Pit2),
polytropic and xenotropic (both use Xpr1 but in different
species) subgroups depending on which receptor they utilize to
enter target cells. There is high degree of homology among
these ENVs and minor variations are responsible for the
complete change of receptor usage.
This has encouraged the idea of designing envelope proteins
with altered tropisms by incorporation of ligands into their
structure. Attempts to do so have met different degrees of
success (Katane et al., 2002; Martin et al., 1998; Wu et al.,
2000).
Here we describe a study to identify the best way of
presenting ligands to redirect the envelope protein of the
Moloney murine leukemia virus to utilize the G-protein-coupled
receptor APJ. We have chosen the APJ as an experimental
target, since it fulfils several criteria for being a gammaretroviral
receptor. 1) It has several transmembrane helices. 2) It functions
as a co-receptor for HIV (Choe et al., 1998). 3) It has a
physiological peptide ligand, apelin, the C-terminal 13 amino
acids of which, bind to it with high affinity (Tatemoto et al.,
1998). 4) The binding of apelin and HIV-envelope maps to the
same area of the receptor (Zhou et al., 2003).
304 S. Bahrami et al. / Virology 363 (2007) 303–309The study presented here is a dual approach. First we
investigated the effect of insertion sites for the ligand on the
function of the envelope protein. Of the thirteen chimeric
envelopes generated, none were able to infect cells through APJ
although most had retained the affinity for the wild type
receptor.
Subsequently, we investigated if presentation of the peptide
ligand in the context of flexible linkers has any effect on the
ability of ENV to use the APJ receptor. A chimeric envelope
protein presenting the apelin peptide flanked by two flexible
peptide sequences, Ser-Gly-Gly-Ser-Gly (SGGSG) was gener-
ated that was able to infect cells through the APJ receptor. The
effect of the linker on the performance of the protein
encouraged us to investigate it further.
We used a previously described vector system to generate
randomized linker libraries and select them for affinity to infect
through the APJ receptor (Bahrami et al., 2003). Several other
linker sequences, with similar effects were isolated, but none
had a greater effect than SGGSG sequence. Therefore, while the
presence of a linker is critical, its exact sequence was of less
importance in this system.
Results
Insertion of apelin peptide at different sites of the Moloney
MLV envelope
In order to design a chimeric envelope that can infect APJ-
expressing cells, we tried to identify sites in this protein that canFig. 1. (A) Schematic presentation of the insertion sites of the apelin peptide in the e
domain, PRR: proline-rich region, CTD: C-terminal domain, VRA: variable regio
designated positions as well as the wild type and VSV-G pseudotyped viruses. The c
plasmid containing a retroviral vector expressing the neomycin resistance gene and ti
APJ expressing D17 cells. NIH-Akv: NIH3T3 cells infected with Akv MLV. The datolerate insertions. The insertion sites were chosen based on
literature, mostly on the work of Rothenberg et al. (2001). The
peptide insertion sites are shown schematically in Fig. 1A. The
exact insertion site is after the amino acid residue number given
in the construct designation (Fig. 1B). In all cases, except for
insertion at position 79 (AP@79), no deletion of the native
Moloney MLV sequence occurred. In the case of AP@79 a
proline residue was deleted as described by Katane et al. (2002).
Among the insertion sites tested, three were located in the N-
terminal part of the protein. Insertions in this part have been
shown to be tolerated in several studies (Marin et al., 1996;
Martin et al., 1998; Rothenberg et al., 2001).
One insertion site was chosen in the VRA region of the
receptor binding domain. Insertion of the ligand for CXCR-4 at
this site has been shown to yield an envelope construct that is
able to mediate entry into CXCR-4-expressing cells, albeit at
low efficiency (Katane et al., 2002). Inclusion of this construct
was mainly meant as a control for the experiments.
The rest of the insertion sites were located in the proline rich
region (PRR) or in the C-terminal domain of the RBD. The
proline-rich region has been shown to tolerate insertion of large
peptides including the green fluorescent protein (Erlwein et al.,
2003) (Fig. 1A).
293T cells were co-transfected with envelope constructs and
Moloney gag-pol-expressing plasmid and an Akv MLV derived
retroviral vector that expresses the neo gene. At 48 h post-
transfection, titers were determined on NIH3T3-, D17-, and
APJ-expressing D17 cells (sorted for high APJ expression by
FACS).nvelope protein of the Moloney murine leukemia virus. RBD: receptor-binding
n A. (B) Titer of the chimeric envelopes containing the apelin peptide at the
himeric envelopes were co-transfected with a gag-pol expressing plasmid and a
ters were measured on the designated cells by serial 10-fold dilutions. D17-APJ:
ta are representative of several independent experiments.
Fig. 2. Effect of the SGGSG linker on the titer of the chimeric envelopes. The
chimeric envelopes were co-transfected (either alone or with equal amount of wt
envelope)with a gag-pol expressing plasmid and a plasmid containing a retroviral
vector expressing the neomycin resistance gene and titers were measured on the
designated cells by serial 10-fold dilutions. D17-APJ: APJ expressing D17 cells.
The data are representative of several independent experiments.
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through APJ although most (all except two) had retained the
ability to use the wild type receptor (Fig. 1B), all of which
showed interference with Akv MLV confirming that infect is
through interaction with wild type mCAT-1 receptor. The
virions produced from cells expressing two of the constructs
had lost their ability to infect murine cells.
In order to rule out any problems with the vector system in
D17 cells, pseudotypes with VSV-G (instead of the Moloney
MLV envelope protein) were made and tested on both NIH3T3
and D17 cells. Although the titer of the VSV-G pseudotype was
slightly lower than that of wild type Moloney MLV ENV
containing virions on murine cells, both NIH3T3 and D17 cells
were infected with equal efficiency suggesting that the low
infection efficiency of the chimeric virions were due to the
inefficiency of the chimeric envelopes.
Effect of a flexible linker flanking Apelin peptide on interaction
with APJ
The inability of all AP@79 constructs to utilize APJ as an
entry receptor was surprising, since insertion of SDF-1α in this
position enables the chimeric envelope to infect CXCR4-
expressing cells (Katane et al., 2002).
Moreover, the inability of the Apelin insertion constructs
(especially AP@79) to infect APJ-expressing cells, despite the
fact that most of these constructs were able to use the mCAT-1
receptor, might be due to inappropriate conformation of the
apelin peptide in the overall protein structure.
Hence, we investigated if presentation of the peptide ligand
in the context of flexible linkers at each end of apelin has any
effect on the ability of the chimeric envelopes to use the APJ
receptor.
To test this, we chose the insertion site at position 79, since
this site has been used to produce infectious, redirected
envelopes (Katane et al., 2002). A short peptide linker with
the sequence Ser-Gly-Gly-Ser-Gly was chosen based on its
presumed flexibility in protein structure (Argos, 1990).
The new constructs were used to create virions as described
above and the titers determined on murine and non-murine cells
with and without APJ. Interestingly the new construct had a
small but significant titer on APJ-expressing dog cells (Fig. 2).
It has previously been reported that targeted envelope
chimeras that lacked the ability to use their intended receptors
acquired this ability upon co-expression with the wild type ENV
(Martin et al., 1998). To test if this is also the case with the
AP@79 and AP@79SGGSG envelopes, these chimeras were
co-expressed with an equal amount of wild type envelope. This
resulted in loss of entry through the APJ receptor, indicating that
the inefficiency of the chimeric envelope cannot be countered in
trans (Fig. 2).
The linker peptide affects binding affinity of the AP@79
chimeric envelope
To determine if the SGGSG linker has an effect on binding of
the chimeric envelopes to APJ or is involved in a post-bindingstep, a virus-binding experiment was performed. The binding of
virions containing either AP@79 or AP@79SGGSG envelope
proteins to APJ-expressing D17 cells was measured using flow
cytometry. The virions were concentrated on a Centricon Plus-
80 (100-kDa cutoff) column and incubated with either murine
NIH3T3 cells or D17 cells (both with and without APJ
expression) at 4 °C for 45 min. Subsequently, the cells were
stained for envelope protein using the anti envelope antibody
83A25 (Evans et al., 1990).
As seen in Fig. 3, both chimeric envelopes bind with high
efficiency to murine cells, whereas none bind to non-permissive
D17 cells. APJ expression in the D17 cells has a very small
effect on binding of AP@79 envelope, but the effect on binding
of AP@79SGGSG envelope is more significant. The binding
affinities are much smaller than those observed for NIH3T3
murine cells, which mirrors the much lower titer on D17 APJ
than on NIH3T3. This suggests that a significant reason for
suboptimal titers of virions containing these envelops is poor
binding to APJ-expressing cells, while a post-binding defect
cannot be ruled out.
Requirements of the linker structure
Presentation of apelin in context of a peptide linker had a
significant effect on enabling the chimeric envelope to use APJ
as an entry receptor. The linker SGGSG was arbitrarily chosen
based on speculation on its flexible secondary structure. It is
possible that other linker sequences are even more efficient in
presenting the apelin peptide in the tertiary structure of the
envelope protein.
To address this issue, we decided to use randomized libraries
in an attempt to isolate better linkers.
The randomized libraries are created and selected using bi-
cistronic vectors as previously described (Bahrami et al., 2003,
2004). Briefly, the bi-cistronic vectors express both neo
resistance and the envelope protein. These vectors are
replication competent in semi-packaging cells expressing the
remaining viral genes gag and pol. The envelope libraries can be
selected for infectivity by means of the neo selection marker.
Fig. 3. Binding of chimeric envelopes expressing apelin at position 79 both with
and without linker. The virus-containing supernatants were concentrated on a
spin-column and incubated with the target cells (murine NIH3T3 or canine D17
with or without APJ). The envelope of the bound virus was labeled by anti
envelope antibody 82A25 and a secondary PE-conjugated goat anti-rat antibody
and measured on a flow cytometer.
306 S. Bahrami et al. / Virology 363 (2007) 303–309The DNA library was made using degenerate primers to
introduce random amino acids at specific positions in the
envelope. Here the pool of randomized vectors was made using
a mixture of primers with 15 or 24 randomized nucleotides,
resulting in linkers that either had 5 or 8 randomized amino
acids at each end of the apelin peptide.
The DNA library was transfected into 293T cells together
with a gag-pol-expressing plasmid. Forty eight hours later,the virions produced were used to transduce semi-packaging
cells that only express gag-pol. The infected semi-packaging
cells will produce virions that contain envelope mutants.
These virions were used to infect D17 cells that express both
gag-pol and the APJ receptor. Hence any virion that is able
to use the APJ receptor will be replication competent in
these cells.
The D17–APJ–gagpol cells were selected by G418. The
resistant population, which contains the vector library, was
subjected to two slightly different selection procedures in order
to isolate envelopes that are able to use APJ as entry receptor.
In the transduction library the virions from one population
were used to transduce naïve D17–APJ–gagpol cells, which
were again selected for G418 resistance. Virions were harvested
and used to repeat the procedure. This procedure was repeated
four times after which colonies were isolated and the envelope
gene of integrated vector proviruses subjected to sequence
analysis.
In the co-culture library the other population of resistance
D17–APJ–gagpol cells (5%) was co-cultured with 95%
naïve D17–APJ–gagpol until confluency. After splitting the
confluent culture, it was selected with G418 until a resistant
population emerged. The new resistant population (which is
a mixture of the transferred and newly infected cells) was
again co-cultured with naïve D17–APJ–gagpol cells and the
procedure was repeated four times, after which colonies were
isolated and subjected to sequence analysis as mentioned
earlier.
The co-culture selection scheme facilitates virus spreading
through cell–cell contacts, whereas the transduction selection
scheme provides more rigorous selection since no resistant cells
are transferred from one step to next.
Several non-wt envelope sequences were identified in this
way (Table 1). Colonies T1, T2 and T3 where isolated through
the transduction selection scheme, whereas colonies C1, C2 and
C3 were isolated through co-culture selection scheme. All of the
envelope chimeras were cloned and used to determine titers.
None of the isolated clones had any better ability to infect
cells through APJ interaction, although all had a markedly
higher titer on APJ-expressing cells than the construct without
any linker (Fig. 4).
All of the envelope sequences, except one, isolated from the
library selection conveyed wild type titer on murine cells and
were expressed on the surface of the producing cells as
efficiently as wild type virus as measured by flow cytometry
(data not shown). The exception was colony C2, which was less
efficiently expressed on the cell surface (data not shown) and
had a correspondingly lower titer on murine cells. Interestingly,
this envelope infected D17–APJ cells as efficiently as the
AP@79SGGSG construct, suggesting that the lower expression
level is countered by a higher affinity for APJ.
Discussion
We have attempted to construct a chimeric envelope that can
infect cells through APJ expression by insertion of APJ's
natural ligand (apelin) into several different sites on the
Fig. 4. Titers mediated by envelopes isolated from library selection. Virions
were produced by semi-packaging cell lines that contained a bi-cistronic vector
expressing the designated envelope construct and the neo resistance marker.
Titers were measured by 10-fold serial dilutions. D17-APJ: APJ expressing D17
cells. The data are representative of several independent experiments.Ta
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307S. Bahrami et al. / Virology 363 (2007) 303–309Moloney murine leukemia virus. All sites used here have been
reported to tolerate insertions and one of the insertion sites (in
the VRA region) is reported to produce re-targeted envelopes
(Erlwein et al., 2003; Katane et al., 2002; Rothenberg et al.,
2001). Nine constructs had comparable titers to wt on murine
cells. Among the rest, two had a markedly lower titer and two
were unable to infect NIH3T3 cell. The four constructs with
impaired activity were constructed based on the insertion sites
found by Rothenberg et al. (2001). In all four cases, insertion of
five amino acids at these sites did not affect the activity of the
envelope protein. The discrepancy with our results might be
because inserted sequence in our case is larger (13 aa). The
infection of murine cells was in all cases mediated by
interaction with mCAT1, as determined by superinfection-
resistance assays. None of the constructs were able to infect
APJ-expressing dog cells.
In a similar study, Wu et al. (2000) have inserted an integrin
binding peptide in various places of the MLV envelope. Our
results are similar to those observed in their study in that the
chimeric envelopes did not infect the M21 human cells (which
express the targeted αvβ3 integrin) and none except for one
showed any significant binding to these cells.
Expression of two five-amino-acid-long linkers at each side
of apelin at position 79 had a significant effect on the chimeric
envelopes ability to infect APJ-expressing cells. This effect
could be related to an increased binding to the APJ receptor:
Where the linkerless construct binds to the APJ-expressing cells
marginally better than wt virus, the construct containing the
linker has a clearly higher binding affinity for APJ. In a study by
Benedict et al. (1999), it was found that an MLV ENV
containing an anti CD34 scFV could transduce cells through
mCAT1 but not CD34 although it could bind to cells expressing
CD34. Interestingly this chimeric envelope mediated a higher
titer on cells expressing both mCAT1 and CD34 suggesting that
the extra level of binding from interaction with CD34 facilitated
transduction.
The linker was chosen for its presumed flexibility in the
overall protein structure. Attempts to isolate better linkers
through selection of random linker libraries produced several
308 S. Bahrami et al. / Virology 363 (2007) 303–309other linkers that had comparable efficiencies, but none was
better than the original SGGSG linker.
Among the isolated clones, several interesting observations
could be made:
One of the clones (C2) has a markedly lower titer on murine
cells, even though its ability to infect through APJ is
comparable to the parental AP@79SGGSG. The lower titer
on murine cells is presumably the result of lower surface
expression of this envelope as determined by flow cytometry
(data not shown). Hence this envelope must have a better
affinity for D17–APJ cells. This clone has also an unintended
mutation in the apelin sequence itself, where the most N-
terminal glutamine is mutated into a lysine. Interestingly,
alanine scanning of apelin-13 peptide has shown that mutation
of the N-terminal Q to an A slightly increases the binding
affinity for APJ (Fan et al., 2003).
Clone T3 seems to have a slightly better ability to infect D17
cells than wild type virus, regardless of APJ expression as
observed in several independent experiments. This might be due
to interaction of the linker sequence with other surface
molecules on D17 cells.
Two of the isolated clones contained the SGGSG linker
downstream of the peptide insert and one upstream. The codons
show that this is due to recombination with the parental
AP@79SGGSG clone during the PCR steps used to make the
DNA library. This, together with the fact that many of the
isolated colonies in the selected libraries were background
AP@79SGGSG clones, suggests that the SGGSG sequence
might be a good choice for a short peptide linker.
Many of the isolated upstream linker sequences contained an
overrepresentation of basic amino acids. These are encoded by
codons rich in adenosines. This is probably due to a bias toward
thymidines in the synthetic primers used to create the library, as
previously observed (Bahrami et al., 2003, 2004). Another
likely explanation is that the basic amino acids facilitate
interaction with the negative charge of the target membrane.
Similarly, polytropic and amphotropic MLVs have several basic
amino acids in tandem in their VRA regions.
The results from library selection show that the presence of a
peptide linker is more important than its specific amino acid
sequence. Therefore, the linker probably enables the apelin
peptide to take on a more favorable conformation for interaction
with APJ. Another explanation is that a larger insert, as long as
it does not interfere with the overall structure of the envelope
protein, would be more exposed (and therefore accessible) on
the binding site of the envelope protein. In agreement with this,
insertion of SDF-1α (68 amino acids long as compared to 13 of
apelin) at the same position by Katane et al. (2002) has
produced an envelope that utilizes CXCR-4 as an entry receptor
around two orders of magnitude more efficiently.
Design of chimeric envelopes through incorporation of
ligands must balance two contradicting requirements. On one
hand the overall structure of the envelope protein must be
preserved, limiting the size of the inserted ligand. On the other
hand the ligand presented must have a suitable conformation in
order to interact with its receptor. Larger, more structured
ligands are better at doing this. Alternatively, unstructuredligands like apelin-13 (Fan et al., 2003) must be presented with
a minimal flexibility needed to acquire the correct conformation
upon binding to their receptors. In other words, the ligands must
be presented in a manner similar to separate protein domains on
the surface of the envelope protein (Argos, 1990).
Materials and methods
Cell cultures
NIH3T3 and the semi-packaging cell line (CeB) (Bahrami
et al., 2003) were grown in Dulbecco's modified Eagle's
medium with Glutamax-1 and 10% (vol./vol.) newborn calf
serum. HEK 293 T and Plat-E (Morita et al., 2000) cells were
grown in the same medium containing 10% fetal calf serum.
D17 cells were grown in MEM-alpha medium with Glutamax-1
and 10% fetal calf serum. All growth media contained
100 U of penicillin/ml and 100 μg of streptomycin/ml. All cells
were incubated at 37 °C in 90% relative humidity and 5.0%
CO2.
D17–APJ cells were made by transfection of a human APJ-
expressing plasmid containing the puromycin resistance gene
and selection with 4.5 μg/ml puromycin until a resistant culture
emerged. The selected population was sorted for high expres-
sion of APJ by FACS.
Envelope expression plasmids
The plasmids were based on the envelope expression plasmid
Eco–Env plasmid from Morita et al. (2000). The apelin peptide
sequence “QRPRLSHKGPMPF” was inserted at the designated
locations by ligation of a PCR overlap extension fragment into
this plasmid. In the case of the AP@79SGGSG construct the
insert had the sequence SGGSGQRPRLSHKGPMPFSGGSG.
All of the inserts were confirmed by sequencing.
Titer measurements
The envelope expression plasmids (8 μg) were co-trans-
fected with gag-pol-expressing plasmid (2 μg) (Morita et al.,
2000) and viral vector expressing the neo resistance marker
(1 μg). Supernatants (with 6 μg/ml polybrene) were transferred
in serial 10-fold dilutions 48 h post-transfection to target cells
seeded at 1×104/cm2 in 6-well dishes. 24 h post-transduction,
the cells were selected with 0.6 mg/ml G418.
The randomized library
The library was made by overlap extension reactions as
described elsewhere (Bahrami et al., 2003, 2004). A mixture
of two randomized primers, one with 5 and the other with 8
NNK codons, was used to make each of the fragments. The
overlap extension product was transfected directly into a
packaging cell line. The supernatant from this cell line was
used to infect murine-based semi-packaging cells (Bahrami et
al., 2003, 2004). Virions produced by the murine-based semi-
packaging cell line was used to transduce the D17–APJ–
309S. Bahrami et al. / Virology 363 (2007) 303–309gagpol cells, which were grown and selected, and used to
either reiterate transduction of or co-culture with fresh D17–
APJ–gagpol cells.
After four such passages, single colonies were isolated
grown and used to prepare genomic DNA which was
subsequently sequenced. The isolated linkers were then cloned
into the wt bi-cistronic vector and used to determine the titers.
Virus binding assay
Virions were concentrated on a Centricon Plus-80 (100-kDa
cutoff) column and incubated with target cells at 4 °C for
45 min. The cells were washed twice using PBS with 2% serum
and incubated with 500 μl of supernatant from 83A25 (Evans et
al., 1990) hybridoma cell line in 4 °C for 45 min. The cells were
subsequently washed twice and 5 μl of secondary antibody
(Goat anti-Rat Ig R-PE conjugate, Harlan Sera-Lab) was added
to the pellet of cells. After incubation at 4 °C for 45 min they
were washed twice in PBS with 2% serum and suspended in a
1% formalin solution and analyzed by a Becton Dickinson
FACSCalibur cytometer.
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